Clinical impact of contrast-enhanced computed tomography combined with low-dose ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management

References

• Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol 2011;29:1844–1854.
   PubMed Web of Science ®Google Scholar
• Delbeke D, Stroobants S, de Kerviler E, et al. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist 2009;14(Suppl. 2):30–40.
   PubMed Web of Science ®Google Scholar
• Meignan M, Barrington S, Itti E, et al. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3–5 October 2012. Leuk Lymphoma 2014;55:31–37.
   PubMed Web of Science ®Google Scholar
• Itti E. Optimization of PET/CT with contrast enhancement in a one-stop shop setting. Paris: Ecole de MAnagement pour les Médecins des Hôpitaux (EMAMH), Assistance Publique-Hôpitaux de Paris (AP-HP) et Ecole Nationale Supérieure des Mines de Paris (MINES ParisTech); 2011.
   Google Scholar
• Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244–1253.
   Web of Science ®Google Scholar
• ICRP. Radiation dose to patients from radiopharmaceuticals: ICRP Publication 80 (Addendum 2 to ICRP Publication 53). New York, NY: International Commission on Radiological Protection; 1998.
   Google Scholar
• EUR16262EN. European guidelines on quality criteria for computed tomography. In: Menzel HG, Schibilla H, Teuten D, editors. European Commission's Radiation Protection Actions; 2003. Available from: http://w3.tue.nl/fileadmin/sbd/Documenten/Leergang/BSM/European_Guidelines_Quality_Criteria_Computed_Tomography_Eur_16252.pdf
   Google Scholar
• Coulot J, Magnier F, Chauchat P, et al. Comparison between effective dose in PET/CT and CT. Méd Nucl 2011;35:156–162.
   Google Scholar
• Picardi M, Soricelli A, Pane F, et al. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. Radiology 2009;251: 574–582.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Vigil B, Gomez-Leon N, Pinilla I, et al. PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. J Nucl Med 2006;47:1643–1648.
   PubMed Web of Science ®Google Scholar
• Kirienko M, Guerra L, Bolis S, et al. Contrast enhanced (ce) CT in staging and end-of-treatment evaluation in lymphoma in the FDG PET/CT era: a need or a habit?J Nucl Med 2012;53:563.
   Google Scholar
• Pinilla I, Gomez-Leon N, Del Campo-Del Val L, et al. Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma. Q J Nucl Med Mol Imaging 2011;55:567–575.
   PubMed Web of Science ®Google Scholar
• Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET scan in lymphoma. Leuk Lymphoma 2009;50:1257–1260.
   PubMed Web of Science ®Google Scholar
• Itti E, Lin C, Dupuis J, et al. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy. J Nucl Med 2009;50:527–533.
   PubMed Web of Science ®Google Scholar
• Meignan M, Gallamini A, Itti E, et al. Report on the third international workshop on interim positron emission tomography in lymphoma held in Menton, France, 26–27 September 2011 and Menton 2011 consensus. Leuk Lymphoma 2012;53:1876–1881.
   PubMed Web of Science ®Google Scholar
• Itti E, Meignan M, Berriolo-Riedinger A, et al. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.Eur J Nucl Med Mol Imaging 2013;40:1312–1320.
   PubMed Web of Science ®Google Scholar
• Elstrom RL, Leonard JP, Coleman M, et al. Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 2008;19:1770–1773.
   PubMed Web of Science ®Google Scholar
• Muzahir S, Graham M. Follow-up of lymphoma with FDG PET-CT: no added advantage of contrast CT. J Nucl Med 2012;53:1367.
   PubMed Web of Science ®Google Scholar
• Moreiras-Plaza M, Albo C, Ares C. Efficacy and safety of femoral vascular access for peripheral blood stem cell (PBSC) collection. Bone Marrow Transplant 2004;33:347–350.
   PubMed Web of Science ®Google Scholar
• Adorno G, Zinno F, Bruno A, et al. Femoral catheters: safety and efficacy in peripheral blood stem cell collection. Int J Artif Organs 1999;22:710–712.
   PubMed Web of Science ®Google Scholar
• Lekovic D, Miljic P, Mihaljevic B. Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma. Thromb Res 2010;126:477–480.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure.N Engl J Med 2007;357:2277–2284.
   PubMed Web of Science ®Google Scholar
• Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004;363:345–351.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Feinendegen LE, Yang C, et al. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 2009;251:13–22.
   PubMed Web of Science ®Google Scholar
• Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?Ann Oncol 2006;17:117–122.
   PubMed Web of Science ®Google Scholar
• Deak Z, Grimm JM, Treitl M, et al. Filtered back projection, adaptive statistical iterative reconstruction, and a model-based iterative reconstruction in abdominal CT: an experimental clinical study. Radiology 2013;266:197–206.
   PubMed Web of Science ®Google Scholar
• Rhee CM, Bhan I, Alexander EK, et al. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 2012;172:153–159.
   PubMed Web of Science ®Google Scholar
• Buck AK, Herrmann K, Stargardt T, et al. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J Nucl Med 2010;51:401–412.
   PubMed Web of Science ®Google Scholar
• Cerci JJ, Trindade E, Pracchia LF, et al. Cost effectiveness of positron emission tomography in patients with Hodgkin's lymphoma in unconfirmed complete remission or partial remission after first-line therapy. J Clin Oncol 2010;28:1415–1421.
   PubMed Web of Science ®Google Scholar
• Vera P, Ouvrier MJ, Hapdey S, et al. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?Eur J Nucl Med Mol Imaging 2007;34:1943–1952.
   PubMed Web of Science ®Google Scholar
• Beyer T, Rosenbaum S, Veit P, et al. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Eur J Nucl Med Mol Imaging 2005;32:1429–1439.
   PubMed Web of Science ®Google Scholar
• Boellaard R, Oyen WJ, Hoekstra CJ, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008;35:2320–2333.
   PubMed Web of Science ®Google Scholar
• Kabickova E, Sumerauer D, Cumlivska E, et al. Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Eur J Nucl Med Mol Imaging 2006;33:1025–1031.
   PubMed Web of Science ®Google Scholar
• Yeoh KW, Mikhaeel NG. Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy?Int J Radiat Oncol Biol Phys 2013;85:14–20.
   PubMed Web of Science ®Google Scholar
• Buchbender C, Heusner TA, Lauenstein TC, et al. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med 2012;53:1244–1252.
   PubMed Web of Science ®Google Scholar
• Lin C, Luciani A, Itti E, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010;20:2027–2038.
   PubMed Web of Science ®Google Scholar
• Lin C, Itti E, Luciani A, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 2011;46:341–349.
   PubMed Web of Science ®Google Scholar